Back
Cue Biopharma Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
75
CUE
Cue Biopharma
Last Price:
1.68
Seasonality Move:
27.28%
Sell
44
BMRN
Biomarin Pharmaceutical
Last Price:
69.88
Seasonality Move:
14.81%
Buy
75
Cue Biopharma (CUE)
is a Buy
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.78. The Score for CUE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- CUE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $70.13. The Score for BMRN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CUE is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $70.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
CUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 71.61 | Buy |
| Chaikin Money Flow: | 514836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 1.5) | Buy |
| Bollinger Bands (100): | (0.6 - 1.3) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.54 | Sell |
| Relative Strength Index (14 RSI): | 40.74 | Sell |
| Chaikin Money Flow: | -69549 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.22 - 70.44) | Buy |
| Bollinger Bands (100): | (73.25 - 88.67) | Sell |
CUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.49 | Buy |
| 20-day SMA: | 1.24 | Buy |
| 50-day SMA: | 0.88 | Buy |
| 200-day SMA: | 1.49 | Buy |
| 8-day EMA: | 1.52 | Buy |
| 20-day EMA: | 1.28 | Buy |
| 50-day EMA: | 1.04 | Buy |
| 200-day EMA: | 1.45 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.16 | Sell |
| 20-day SMA: | 69.87 | Buy |
| 50-day SMA: | 77.51 | Sell |
| 200-day SMA: | 83.51 | Sell |
| 8-day EMA: | 70.11 | Buy |
| 20-day EMA: | 70.88 | Sell |
| 50-day EMA: | 75.01 | Sell |
| 200-day EMA: | 82.32 | Sell |
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.94 per share.
Cue Biopharma Technical Analysis
| Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||